REGIONAL HEALTH PROPERTIES, INC
A specialized REIT providing essential infrastructure to healthcare professionals with a focus on stable long-term lease structures.
A specialized REIT providing essential infrastructure to healthcare professionals with a focus on stable long-term lease structures.
Investors might consider RHEP for exposure to the resilient healthcare real estate sector where demand for medical office space remains inelastic regardless of economic downturns, potentially offering upside if the company successfully reduces its substantial debt burden or acquires undervalued assets at a discount.
The stock carries significant downside risk due to a negative shareholders' equity of $-2.9M and a retained earnings deficit of $-85.1M, suggesting fundamental financial distress that could limit growth capital availability or trigger dilution through further equity issuance.
Regional Health Properties Inc. (RHEP) operates as a real estate investment trust focused on owning and managing medical office buildings across the United States, serving healthcare providers in primary care, specialty, and outpatient surgery markets.
Despite a slight stabilization in revenue recovery from $17.2M in 2023 to $18.3M in 2024, the company continues to report net losses of $-3.2M, indicating that operational cash flows are insufficient to cover capital expenditures and debt service requirements without external financing.
The medical office building sector provides stable cash flows driven by long-term leases to essential healthcare providers, but faces headwinds from rising interest rates and construction costs that can compress margins for existing operators with high leverage.
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | $35.9M | $17.2M | $18.3M |
| Cost of Revenue | $0 | $0 | $0 |
| Gross Profit | $35.9M | $17.2M | $18.3M |
| Operating Expenses | $42.7M | $18.0M | $18.2M |
| Operating Income | $-6.8M | $-804.0K | $161.0K |
| G&A | $4.7M | $4.0M | $5.4M |
| Stock-Based Comp | $233.0K | $357.0K | $114.0K |
| D&A | $2.4M | $2.3M | $2.1M |
| Depreciation | $2.0M | $1.8M | $1.6M |
| Amortization | $438.0K | $438.0K | $432.0K |
| Other OpEx | $38.1M | $14.0M | $12.8M |
| Non-Operating Income | $0 | $0 | $0 |
| Interest Expense | $2.5M | $2.8M | — |
| Pre-Tax Income | $-6.8M | $-804.0K | $161.0K |
| Income Tax | $45.0K | $3.1M | $3.4M |
| Continuing Ops | $-6.9M | $-3.9M | $-3.2M |
| Discontinued Ops | $0 | $0 | $0 |
| Net Income | $-6.9M | $-3.9M | $-3.2M |
| Minority Interest | $0 | $0 | $0 |
| Net to Common | $-6.9M | $-3.9M | $-3.2M |
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Cash & Equivalents | $800.0K | $1.0M | $582.0K |
| Accounts Receivable | $6.3M | $1.4M | $3.4M |
| Prepaid Expenses | $700.0K | $600.0K | $600.0K |
| PP&E (Net) | $46.6M | $45.3M | $33.5M |
| Intangibles | $12.3M | $11.8M | $11.4M |
| Goodwill | $1.6M | $1.6M | $1.6M |
| Operating Leases | $2.8M | $2.6M | $2.2M |
| Total Assets | $68.6M | $62.2M | $60.5M |
| Long-Term Debt | $52.2M | $50.7M | $49.7M |
| Total Liabilities | $64.9M | $62.0M | $63.4M |
| Shareholders' Equity | $3.7M | $185.0K | $-2.9M |
| Paid-In Capital | $62.7M | $63.1M | $63.2M |
| Retained Earnings | $-121.4M | $-81.9M | $-85.1M |
| Total L&E | $68.6M | $62.2M | $60.5M |
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Net Income (CFO) | $-6.9M | $-3.9M | $-3.2M |
| Non-Cash Adjustments | $-2.3M | $13.4M | $2.3M |
| Working Capital Changes | $5.6M | $-5.8M | $2.9M |
| Cash from Operations | $-3.6M | $3.7M | $1.9M |
| Capital Expenditures | $281.0K | $958.0K | $530.0K |
| Cash from Investing | $-281.0K | $-958.0K | $-530.0K |
| Share Buybacks | $46.0K | — | — |
| Cash from Financing | $-2.1M | $-2.5M | $-2.1M |
| FX Effect | $0 | $0 | $0 |
| Net Change in Cash | $-5.9M | $275.0K | $-712.0K |
| Beginning Cash | $9.8M | $3.9M | $4.2M |
| Ending Cash | $3.9M | $4.2M | $3.5M |
Primary revenue streams include rental income from long-term leases to physicians and surgical groups, property management fees generated from operating the facilities, and ancillary services such as tenant improvements or leasing commissions.
Significant debt load of $49.7M relative to total equity creating leverage risk, persistent net losses impacting retained earnings, declining revenue from 2022 levels indicating sensitivity to market cycles or tenant vacancies, and potential interest rate sensitivity affecting refinancing costs for long-term debt.
Strong asset location in high-growth suburban markets with limited supply of new medical office buildings, a diversified tenant base reducing concentration risk, and experienced management team specializing in healthcare real estate capital markets.
Not financial advice. All content is for informational purposes only. Data may contain errors. Consult a qualified financial advisor before making investment decisions.